Versatile Recombinant Rat Reg4 Protein (fc Tag) Collection [UAOo5R1n]

Versatile Recombinant Rat Reg4 Protein (fc Tag) Collection [UAOo5R1n]: A Cutting-Edge Research Tool

Introducing our Versatile Recombinant Rat Reg4 Protein (fc Tag) Collection [UAOo5R1n], a premium research tool designed for scientists seeking to delve into the intricate world of regenerative medicine and gastrointestinal diseases. This recombinant protein is derived from HEK293 cells, ensuring high purity and reliability. The Fc Tag provides a robust platform for various research applications, including protein-protein interactions and functional studies.

Key Features and Specifications

Our Versatile Recombinant Rat Reg4 Protein (fc Tag) Collection [UAOo5R1n] boasts several standout features and specifications. It is synthesized with a Met1-Pro157 sequence, corresponding to the full-length protein, and has a calculated molecular weight of 42.9 kDa, with an observed molecular weight of 49 kDa. This protein is highly expressed in the gastrointestinal tract and is significantly upregulated in colon adenocarcinoma, pancreatic cancer, gastric adenocarcinoma, and inflammatory bowel disease. The product is >80% pure as determined by reducing SDS-PAGE and contains < 1.0 EU per μg of protein as determined by the LAL method, ensuring a safe and effective research experience.

Applications and Benefits

The Versatile Recombinant Rat Reg4 Protein (fc Tag) Collection [UAOo5R1n] is a versatile tool for researchers studying the regenerative gene family, cell growth, cell survival, cell adhesion, and resistance to apoptosis. Its involvement in malignancy in various organs, including the stomach, colorectum, pancreas, and prostate, makes it a valuable asset for investigating the development and progression of colorectal cancer and intestinal morphogenesis. By utilizing this protein, researchers can explore the potential of REG4 as a predictive biomarker in clinical settings, leading to better understanding and treatment strategies for gastrointestinal diseases.